Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis-Reference-Cited by-同舟云学术

Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis

Published:2020-09-03 Issue:17 Volume:5 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Wilson Jennifer G.,Simpson Laura J.,Ferreira Anne-Maud^ORCID,Rustagi Arjun^ORCID,Roque Jonasel,Asuni Adijat,Ranganath Thanmayi^ORCID,Grant Philip M.,Subramanian Aruna,Rosenberg-Hasson Yael,Maecker Holden T.,Holmes Susan P.,Levitt Joseph E.,Blish Catherine A.,Rogers Angela J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/140289/files/pdf

Reference16 articles.

1. Clinical and immunological features of severe and moderate coronavirus disease 2019

2. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

3. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

4. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

5. National Library of Medicine ClinicalTrials.gov website. https://clinicaltrials.gov Accessed June 22, 2020

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An exploratory analysis of associations of genetic variation with the efficacy of tocilizumab in severe COVID-19 patients. A pharmacogenetic study based on next-generation sequencing;Frontiers in Pharmacology;2024-09-13

2. Pulmonary delivery of icariin-phospholipid complex prolongs lung retention and improves therapeutic efficacy in mice with acute lung injury/ARDS;Colloids and Surfaces B: Biointerfaces;2024-09

3. Deciphering the mechanism of cimifugin in mitigating LPS-induced neuroinflammation in BV-2 cells;Allergologia et Immunopathologia;2024-07-01

4. sTREM-1 as a Predictive Biomarker for Disease Severity and Prognosis in COVID-19 Patients;Journal of Inflammation Research;2024-06

5. Pharmacological mechanism of action of Lianhua Qingwen in the treatment of COVID‐19 and facial neuritis;World Journal of Otorhinolaryngology - Head and Neck Surgery;2024-05-30